Teclison is a clinical-stage biotech company focusing on novel cancer therapeutics. Their platform technology induces tumors into necrosis and converts cancer into a therapeutic vaccine. The platform aims to enhance the therapeutic benefits of immunotherapy, and can be leveraged to treat nearly all solid tumors. The company also provides an approach to address the unique challenges of immunotherapy in liver metastasis.
Ray Lee, M.D., Ph.D.
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.